Preventive Medicine

First food: business of taste

Good Food is First Food. It is not junk food. It is the food that connects nature and nutrition with livelihoods. This food is good for our health; it comes from the rich biodiversity of our regions; it provides employment to people. Most importantly, cooking and eating give us pleasure. …

US biochemical engineer wins Millennium Prize

US biochemical engineer Frances Arnold gives a speech to accept the Millennium Technology Prize 2016 during the award ceremony in Helsinki, Finland, on May 24, 2016. Arnold won the million-euro technology prize for her work on "directed evolution". AMERICAN biochemical engineer Frances Arnold, whose discoveries in “directed evolution” have helped …

Antibody shields monkeys from HIV-like virus for months

Just one shot of a lab-produced antibody protected macaques against a sort of monkey HIV for nearly six months, said a study Wednesday into a potential vaccine alternative. Exposed to simian HIV (SHIV) once a week, non-treated monkeys contracted the virus after just three weeks on average, the researchers said, …

Danish researchers behind vaccine breakthrough

A Danish research team from the University of Copenhagen has designed a simple technique that makes it possible to quickly and easily develop a new type of vaccines. The simple and effective technique will pave the way for effective vaccines against not only infectious diseases but also cancer and other …

Revolutionary antibiotics will save the world

An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe. The study is published in the Scientific Reports. Scientists discovered how the E. coli bacterium can survive in the human gut - earlier the question how they breathe …

New mouse model leads way for Zika drug, vaccine tests

A team of scientists has developed first animal model for testing drugs and vaccines to battle Zika virus. The University of Texas Medical Branch researchers' genetically mice have already yielded some clues about the virus' pathogenesis. Lead author Shannan Rossi said that there is a huge demand to screen antivirals …

New vaccine may prevent multiple strains of the flu

Each year, researchers identify influenza strains expected to circulate during flu season and manufacture a vaccine aimed at them. Many years, strains not expected to pose a threat emerge, sickening people who have been vaccinated. Scientists at the University of Georgia and Sanofi Pasteur developed a vaccine for H1N1 influenza …

New treatment regimen cuts severity of drug-resistant malaria in pregnancy

A two-drug preventive treatment greatly reduces the severity of malaria during pregnancy, according to a study funded by the National Institutes of Health. The treatment provides an alternative for many parts of Africa where the malaria-causing parasite Plasmodium falciparum has grown resistant to standard treatment. Pregnancy lowers the body's defenses …

Scientists discover white blood cell in birds that destroys fatal fungal infection

A specialised white blood cell found in birds can destroy an infection that claims hundreds of thousands of human deaths every year, scientists have claimed. Birds are believed to carry the cryptococcus neoformans fungus that can prove fatal for people with weakened immune systems, and particularly individuals with HIV. Despite …

Ebola: $5m vaccine deal announced

The Vaccine Alliance, Gavi, has signed a $5m (£3.5m) deal for an Ebola vaccine, to protect against future outbreaks of the deadly disease. The deal commits pharmaceutical company Merck to keeping 300,000 vaccines ready for emergency use or further clinical trials. It will also submit an application to license the …

Brazil to fund development of vaccine for Zika virus

The Brazilian government announced it will direct funds to a biomedical research center to help develop a vaccine against a virus linked to brain damage in babies. Health Minister Marcelo Castro said Friday that the goal is for the Sao Paulo-based Butantan Institute to develop "in record time" a vaccine …

Cuba develops vaccine for chronic hepatitis B

HAVANA, Cuba (CMC) — The new Cuban vaccine for the treatment of chronic hepatitis B is currently undergoing clinical trials in Cuba and eight Asian countries, with the cooperation of the French company Abivax. Researchers say the new product -- HeberNasvac -- developed by researchers of the Centre for Genetic …

Leaky vaccines help more virulent viruses evolve

Some vaccines have been found to make some viruses more harmful via evolution, a new study has warned. The report, published in PLOS Biology, states that experiments with herpesvirus – a large family of DNA responsible for many diseases – shows some vaccines can only prove to make matters worse. …

Nigeria: Human Trials of HIV Vaccine Begin After Partial Success in Monkeys

The success of an experimental vaccine trial with rhesus monkeys is motivating a pharmaceutical company to undertake experimental HIV vaccine tests in Thailand, East and South Africa, and the United States of America US, with 400 healthy participants taking part in the first phase of the trials. Scientists say the …

Nigeria: New Study in Nigeria Finds One in 10 Malaria Drugs Is of Poor Quality

Abuja — A new research released recently has indicated that substandard medicines are more prevalent than fakes in the world's most malaria-burdened country, Nigeria. A rigorous analysis of more than 3,000 anti-malaria drugs purchased in Enugu, Nigeria found 9.3 per cent to be of poor quality, according to a new …

W.H.O. Plan Aims to Combat Resistance to Antibiotic Drugs

GENEVA — United Nations member states agreed Monday to a plan to tackle resistance to antibiotic drugs, spurred by warnings of a catastrophe for public health and heavy economic losses if they did not act. The plan is due to be adopted Tuesday at a plenary session of the World …

Nigeria: Malaria Vaccine Less Effective Than Expected

HOPES of a universal, commercially licensed malaria vaccine this year may have dimmed as the first candidate malaria vaccine to reach phase III clinical trials, though safe, has been found to provide only modest protection for infants. Results of the RTS,S/AS01 vaccine clinical trial that is being conducted across 11 …

Malaria 'viral' vaccine shows promising early results

A trial of a malaria vaccine that targets the most dangerous variety of parasite that causes the disease has shown some positive early results. The vaccine, developed at Oxford University, was 67% effective in a study of 121 men in Kenya, it found. Encouraging results have now been recorded for …

Most countries not protecting antibiotics, says WHO

Three-quarters of countries do not have plans in place to preserve antimicrobial medicines, the World Health Organization says. The body has repeatedly warned that the globe is heading into a "post-antibiotic era" in which much of modern medicine becomes impossible. Its report showed "a lot more needs to be done" …

Antibiotics: US discovery labelled 'game-changer' for medicine

The decades-long drought in antibiotic discovery could be over after a breakthrough by US scientists. Their novel method for growing bacteria has yielded 25 new antibiotics, with one deemed "very promising". The last new class of antibiotics to make it to clinic was discovered nearly three decades ago. The study, …

HIV’s infection tactics could guide AIDS vaccine, studies find

New research that sheds light on the methods and machinery used by HIV to infect cells provides insight into the tricky virus that potentially could guide the development of a vaccine against the cause of AIDS, according to U.S. government and other scientists. Separate studies published on Wednesday describe in …

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. ...
  7. 8

IEP child categories loading...